416
Participants
Start Date
November 30, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
October 31, 2011
RAD001
The dose of RAD001 was 10 mg/day. Patients were instructed to take two tablets (5 mg each) by mouth every day.
Placebo
Novartis Investigative Site, Randwick
Novartis Investigative Site, Camperdown
Novartis Investigative Site, Westmead
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, South Brisbane
Novartis Investigative Site, Woodville
Novartis Investigative Site, New York
Novartis Investigative Site, Buffalo
Novartis Investigative Site, Pittsburgh
Novartis Investigative Site, Genova
Novartis Investigative Site, Milan
Novartis Investigative Site, Baltimore
Novartis Investigative Site, Cremona
Novartis Investigative Site, Morgantown
Novartis Investigative Site, Pavia
Novartis Investigative Site, Chapel Hill
Novartis Investigative Site, Raleigh
Novartis Investigative Site, Durham
Novartis Investigative Site, Madrid
Novartis Investigative Site, Hanover
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Orlando
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Kassel
Novartis Investigative Site, Louisville
Novartis Investigative Site, Modena
Novartis Investigative Site, Canton
Novartis Investigative Site, Saint-Herblain Cédex
Novartis Investigative Site, Valencia
Novartis Investigative Site, Indianapolis
Novartis Investigative Site, Indianapolis
Novartis Investigative Site, Detroit
Novartis Investigative Site, Mainz
Novartis Investigative Site, Minneapolis
Novartis Investigative Site, Lille
Novartis Investigative Site, Frankfurt/M
Novartis Investigative Site, St Louis
Novartis Investigative Site, Columbia
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Lyon
Novartis Investigative Site, Fayetteville
Novartis Investigative Site, Paris
Novartis Investigative Site, Dallas
Novartis Investigative Site, Tyler
Novartis Investigative Site, Bedford
Novartis Investigative Site, San Antonio
Novartis Investigative Site, Napoli
Novartis Investigative Site, München
Novartis Investigative Site, Las Vegas
Novartis Investigative Site, Santa Monica
Novartis Investigative Site, San Francisco
Novartis Investigative Site, Villejuif
Novartis Investigative Site, Sacramento
Novartis Investigative Site, Portland
Novartis Investigative Site, Spokane
Novartis Investigative Site, Duarte
Novartis Investigative Site, Ocoee
Novartis Investigative Site, Seattle
Novartis Investigative Site, Edmonton
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Hamilton
Novartis Investigative Site, London
Novartis Investigative Site, Toronto
Novartis Investigative Site, Toronto
Novartis Investigative Site, Montreal
Novartis Investigative Site, Dresden
Novartis Investigative Site, Perugia
Novartis Investigative Site, Roma
Novartis Investigative Site, Akita
Novartis Investigative Site, Chiba
Novartis Investigative Site, Matsuyama
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Tsukuba
Novartis Investigative Site, Kurashiki
Novartis Investigative Site, Osaka
Novartis Investigative Site, Sayama
Novartis Investigative Site, Sunto-gun
Novartis Investigative Site, Utsunomiya
Novartis Investigative Site, Tokushima
Novartis Investigative Site, Chuo-ku
Novartis Investigative Site, Utrecht
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Leiden
Novartis Investigative Site, Nijmegen
Novartis Investigative Site, Gdañsk
Novartis Investigative Site, Lodz
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Barcelona
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Barcelona
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY